Woodline Partners’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.7M | Sell |
1,241,938
-215,157
| -15% | -$4.97M | 0.15% | 205 |
|
|
2025
Q1 | $39.3M | Sell |
1,457,095
-395,092
| -21% | -$10.7M | 0.26% | 121 |
|
|
2024
Q4 | $99.2M | Buy |
1,852,187
+251,924
| +16% | +$13.5M | 0.67% | 15 |
|
|
2024
Q3 | $72.7M | Buy |
1,600,263
+1,299,438
| +432% | +$59M | 0.61% | 30 |
|
|
2024
Q2 | $12.6M | Buy |
300,825
+270,977
| +908% | +$11.4M | 0.12% | 224 |
|
|
2024
Q1 | $1.12M | Buy |
+29,848
| New | +$1.12M | 0.01% | 452 |
|
|
2023
Q4 | – | Sell |
-85,708
| Closed | -$864K | – | 564 |
|
|
2023
Q3 | $864K | Sell |
85,708
-51,592
| -38% | -$520K | 0.01% | 458 |
|
|
2023
Q2 | $1.63M | Hold |
137,300
| – | – | 0.02% | 450 |
|
|
2023
Q1 | $1.66M | Sell |
137,300
-368,064
| -73% | -$4.45M | 0.02% | 433 |
|
|
2022
Q4 | $6.66M | Buy |
505,364
+105,183
| +26% | +$1.39M | 0.09% | 271 |
|
|
2022
Q3 | $5.42M | Buy |
400,181
+113,798
| +40% | +$1.54M | 0.08% | 275 |
|
|
2022
Q2 | $3.5M | Buy |
286,383
+8,060
| +3% | +$98.4K | 0.05% | 310 |
|
|
2022
Q1 | $3.99M | Buy |
278,323
+48
| +0% | +$688 | 0.06% | 266 |
|
|
2021
Q4 | $5.49M | Sell |
278,275
-21,756
| -7% | -$429K | 0.08% | 270 |
|
|
2021
Q3 | $6.49M | Sell |
300,031
-34,229
| -10% | -$740K | 0.11% | 219 |
|
|
2021
Q2 | $8.34M | Buy |
+334,260
| New | +$8.34M | 0.16% | 152 |
|